(f) cause or permit any of its subsidiaries to, without approval of the Board of Directors of the Corporation, sell, issue, sponsor, create or distribute any digital tokens, cryptocurrency or other blockchain-based assets (collectively, “Tokens”), including through a pre-sale, initial coin offering, token distribution event or crowdfunding, or through the issuance of any instrument convertible into or exchangeable for Tokens, in each case without the approval of the Board of Directors of the Corporation, including a majority of the Preferred Directors;
(g) create, adopt, amend, terminate or repeal any equity (or equity linked) compensation plan;
(h) create, or authorize the creation of, or issue, or authorize the issuance of any debt security or create any lien or security interest (except for purchase money liens or statutory liens of landlords, mechanics, materialmen, workmen, warehousemen and other similar persons arising or incurred in the ordinary course of business) or incur other indebtedness for borrowed money, including but not limited to obligations and contingent obligations under guarantees, or permit any subsidiary to take any such action with respect to any indebtedness for borrowed money, if the aggregate outstanding indebtedness for borrowed money incurred or guaranteed by the Corporation and its subsidiaries following such action would exceed $1,000,000, other than equipment leases or trade payables incurred in the ordinary course of business, unless such indebtedness has received the prior approval of the Board of Directors of the Corporation, including a majority of the Preferred Directors;
(i) increase or decrease the authorized number of directors constituting the Board of Directors of the Corporation or any change in the method of designating such directors; or
(j) enter into any transaction with any officer, director or employee of the Corporation, or member of their immediate family, or any holder of capital stock of the Corporation, except for (1) expense advances or reimbursements in the ordinary course of business or (2) transactions that are approved by a majority of the Board of Directors of the Corporation, including a majority of the disinterested directors of the Corporation.
3.4 Series B Preferred Stock Protective Provisions. At any time when at least 5,203,483 shares of Series B Preferred Stock (subject to appropriate adjustment in the event of any stock dividend, stock split, combination or other similar recapitalization with respect to the Series B Preferred Stock) are outstanding, the Corporation shall not, either directly or indirectly by amendment, merger, consolidation or otherwise, do any of the following without (in addition to any other vote required by law or this Amended and Restated Certificate of Incorporation) the written consent or affirmative vote of the holders of a majority of the shares of Series B Preferred Stock then outstanding (the “Series B Majority”), given in writing or by vote at a meeting, consenting or voting (as the case may be) separately as a class, and any such act or transaction entered into without such consent shall be null and void ab initio, and of no force or effect:
3.4.1 amend, alter or repeal this Amended and Restated Certificate of Incorporation or the Bylaws of the Corporation in any manner if such amendment, alteration or repeal would adversely affect the powers, preferences, or rights of the shares of Series B Preferred Stock in a manner that would adversely affect such shares of Series B Preferred Stock but does not so affect all shares of all series of Preferred Stock;
3.4.2 increase or decrease the authorized number of shares of Series B Preferred Stock;
3.4.3 amend or waive the requirements for a Qualified IPO or a Qualified SPAC Transaction; or
8.